Influence of proxy respondents and mode of administration on health status assessment following central nervous system tumours in childhood
- PMID: 9062441
- DOI: 10.1023/a:1026465411669
Influence of proxy respondents and mode of administration on health status assessment following central nervous system tumours in childhood
Abstract
Central nervous system (CNS) tumours account for 20% of childhood cancers. Survivors often experience severe physical, neuropsychological and social sequelae of the disease and its treatment. Health status assessment in these individuals is an essential clinical outcome measure, yet little consensus exists regarding the optimum methodology. The influence of proxy respondents (parents, physiotherapists and doctors) and mode of administration (home and clinic) in which assessments is performed has been evaluated in a cohort of 37 survivors of childhood CNS tumours. A health-related quality of life (HRQOL) questionnaire, incorporating the Mark II and III Health Utilities Indices, was completed at home and in clinic by patients and parents. Doctors and physiotherapists completed this questionnaire plus Lansky Play-Performance and Karnofsky Performance scores. No significant differences between raters for single attribute scores occurred either at home or in clinic, although a wide range of agreement (kappa = 0.05-1.00, percentage agreement 53-100%) between observers was revealed. Most agreement occurred between parents and patients: this was greatest on home completion (kappa = 0.48-1.00, percentage agreement 53-100%). Doctors and physiotherapists agreed less on subjective attributes (emotion, cognition and pain). Better if responses were classified as normal and abnormal. Inter-observer agreement was greater for the HRQOL questionnaire than for Karnofsky and Lansky scores. Home completion of questionnaires provides a reliable, acceptable and convenient method of assessing health status.
Similar articles
-
Applicability of the Health Utilities Index to a population of childhood survivors of central nervous system tumours in the U.K.Eur J Cancer. 1999 Feb;35(2):256-61. doi: 10.1016/s0959-8049(98)00367-0. Eur J Cancer. 1999. PMID: 10448268
-
Health-related quality of life in survivors of tumours of the central nervous system in childhood--a preference-based approach to measurement in a cross-sectional study.Eur J Cancer. 1999 Feb;35(2):248-55. doi: 10.1016/s0959-8049(98)00366-9. Eur J Cancer. 1999. PMID: 10448267
-
School behaviour and health status after central nervous system tumours in childhood.Br J Cancer. 1997;76(5):643-50. doi: 10.1038/bjc.1997.439. Br J Cancer. 1997. PMID: 9303365 Free PMC article.
-
Consideration of the use of health status, functional outcome, and quality-of-life to monitor neonatal intensive care practice.Pediatrics. 1999 Jan;103(1 Suppl E):319-28. Pediatrics. 1999. PMID: 9917474 Review.
-
Development and field testing of a neuro psychomotor multidimensional grid for the assessment of children with cns tumor.Pediatr Hematol Oncol. 2022 Mar;39(2):108-120. doi: 10.1080/08880018.2021.1948648. Epub 2021 Jul 22. Pediatr Hematol Oncol. 2022. PMID: 34289789 Review.
Cited by
-
Cost-effectiveness of neonatal surgery: first greeted with scepticism, now increasingly accepted.Pediatr Surg Int. 2008 Feb;24(2):119-27. doi: 10.1007/s00383-007-2045-0. Epub 2007 Nov 6. Pediatr Surg Int. 2008. PMID: 17985140 Review.
-
Influence of proxy respondents in children's health interview surveys.J Epidemiol Community Health. 1999 Jan;53(1):38-42. doi: 10.1136/jech.53.1.38. J Epidemiol Community Health. 1999. PMID: 10326051 Free PMC article.
-
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.Pediatr Blood Cancer. 2017 Mar;64(3):10.1002/pbc.26261. doi: 10.1002/pbc.26261. Epub 2016 Sep 21. Pediatr Blood Cancer. 2017. PMID: 27650708 Free PMC article.
-
Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?Pharmacoeconomics. 2015 May;33(5):489-509. doi: 10.1007/s40273-015-0259-x. Pharmacoeconomics. 2015. PMID: 25715975 Free PMC article.
-
Patient-Reported Outcomes in Pediatric Patients With Cancer.Am Soc Clin Oncol Educ Book. 2023 May;43:e390272. doi: 10.1200/EDBK_390272. Am Soc Clin Oncol Educ Book. 2023. PMID: 37172266 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources